InspireMD Inc (NSPR)
2.30
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
2.30
0.00 (0.00%)
Pre-Market: 20:00
InspireMD Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 37.53M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.103M |
| June 30, 2022 | -0.037M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.035M |
| June 30, 2021 | 0.001M |
| March 31, 2021 | 35.07M |
| December 31, 2020 | 4.068M |
| September 30, 2020 | 0.09M |
| June 30, 2020 | 12.23M |
| March 31, 2020 | 0.003M |
| December 31, 2019 | 0.004M |
| September 30, 2019 | 4.285M |
| June 30, 2019 | 2.03M |
| March 31, 2019 | 0.016M |
| December 31, 2018 | 0.019M |
| September 30, 2018 | 6.571M |
| June 30, 2018 | 4.062M |
| March 31, 2018 | 2.718M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.75M |
| September 30, 2017 | -0.01M |
| June 30, 2017 | -0.09M |
| March 31, 2017 | 3.983M |
| December 31, 2016 | -1.053M |
| September 30, 2016 | 12.58M |
| June 30, 2016 | -0.336M |
| March 31, 2016 | 0.516M |
| December 31, 2015 | -0.988M |
| September 30, 2015 | -0.94M |
| June 30, 2015 | -1.015M |
| March 31, 2015 | 11.56M |
| December 31, 2014 | 6.448M |
| September 30, 2014 | 1.939M |
| June 30, 2014 | -0.038M |
| March 31, 2014 | -0.077M |
| September 30, 2013 | |
| June 30, 2013 | 14.09M |
| March 31, 2013 | -0.02M |
| December 31, 2012 | 0.617M |
| September 30, 2012 | 0.432M |
| March 31, 2012 | -0.094M |
| December 31, 2011 | -0.094M |
| September 30, 2011 | 1.407M |
| June 30, 2011 | -0.098M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.103M
Minimum
Sep 2022
37.53M
Maximum
Jun 2023
4.757M
Average
0.0005M
Median
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 166.33M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.064M |
| Cash from Investing (Quarterly) | 4.817M |
| Free Cash Flow | -17.16M |
| Free Cash Flow Per Share (Quarterly) | -0.1536 |
| Free Cash Flow to Equity (Quarterly) | -5.259M |
| Free Cash Flow Yield | -24.28% |